ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag drug development cell molecular biology neuroscience developmental biology evolution

Microfluidics: Biology’s Liquid Revolution
Laura Tran, PhD | Feb 26, 2024 | 8 min read
Microfluidic systems redefined biology by providing platforms that handle small fluid volumes, catalyzing advancements in cellular and molecular studies.
Exploring the Past, Present, and Future of Brain Organoids 
Niki Spahich, PhD | Feb 18, 2024 | 5 min read
Paola Arlotta seeks to understand the complex symphony of brain development in vitro by using organoid models.
Using Brain Organoids in Human Health and Disease Research
Using Brain Organoids in Human Health and Disease Research
The Scientist | Jan 17, 2024 | 1 min read
Learn how scientists across life science and engineering disciplines join forces to build brain organoids that mimic neurodevelopment.
On the left is a normally developing mouse embryo, on the right is a slightly larger mouse embryo that also contains horse cells that glow green.
Chimera research opens new doors to understanding and treating disease
Hannah Thomasy, PhD, Drug Discovery News | Aug 9, 2023 | 10 min read
Animals with human cells could provide donor organs or help us understand neuropsychiatric disorders.
Monoclonal Antibodies Find Utility In Cell Biology
Ricki Lewis | Dec 11, 1994 | 10+ min read
But, just as antibodies are finding increasing utility in cell biology, a new Food and Drug Administration classification for those products with clinical utility may affect researchers' access to the important technology (see accompanying story). Monoclonal History MAbs were born in 1975, when Georges Kohler and Cesar Milstein at the Medical Research Council Laboratories in Cambridge, England, fused two types of cells to form a hy
Monoclonal Antibodies Find Utility In Cell Biology
Ricki Lewis | Dec 11, 1994 | 10+ min read
But, just as antibodies are finding increasing utility in cell biology, a new Food and Drug Administration classification for those products with clinical utility may affect researchers' access to the important technology (see accompanying story). Monoclonal History MAbs were born in 1975, when Georges Kohler and Cesar Milstein at the Medical Research Council Laboratories in Cambridge, England, fused two types of cells to form a hy
Neuroscience Meeting Schedule : At A Glance
Neeraja Sankaran | Oct 16, 1994 | 2 min read
Decade of the Brain Lecture, 8:00 p.m.-9:00 p.m.: "Consolidating the gains in brain" Presidential Special Lecture, 10:00 a.m.-11:00 a.m.: "Cell death in development and disease" History of Neuroscience Lecture, 1:00 p.m.-2:00 p.m.: "Evolving concepts of function of the neocortex" 11:15 a.m.-12:15 p.m.: "Molecular studies of physiological functions of glutamate receptor" 4:15 p.m.-5:15 p.m.: "The molecular biology and biophysi
Neuroscience Meeting Schedule : At A Glance
Neeraja Sankaran | Oct 16, 1994 | 2 min read
Decade of the Brain Lecture, 8:00 p.m.-9:00 p.m.: "Consolidating the gains in brain" Presidential Special Lecture, 10:00 a.m.-11:00 a.m.: "Cell death in development and disease" History of Neuroscience Lecture, 1:00 p.m.-2:00 p.m.: "Evolving concepts of function of the neocortex" 11:15 a.m.-12:15 p.m.: "Molecular studies of physiological functions of glutamate receptor" 4:15 p.m.-5:15 p.m.: "The molecular biology and biophysi
A rendering of a human brain in blue on a dark background with blue and white lines surrounding the brain to represent the construction of new connections in the brain.
Defying Dogma: Decentralized Translation in Neurons
Danielle Gerhard, PhD | Sep 8, 2023 | 10+ min read
To understand how memories are formed and maintained, neuroscientists travel far beyond the cell body in search of answers.
Researchers in George Church&rsquo;s lab modified wild type ADK proteins (left) in <em >E.coli</em>, furnishing them with an nonstandard amino acid (nsAA) meant to biocontain the resulting bacterial strain.
A Pioneer of The Multiplex Frontier
Rashmi Shivni, Drug Discovery News | May 20, 2023 | 10 min read
George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.

Run a Search

ADVERTISEMENT